Display options
Cite
Rajaei B, Roelofsen AL, Shokrollahi E, et al. 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation. 2021;105(12):S26doi: 10.1097/01.tp.0000804432.75585.bf.
Rajaei, B., Roelofsen, A. L., Shokrollahi, E., Brinkhof, B., Naumovska, E., van der Sluis, R. J., Nieveen, M., Engelse, M., de Koning, E., & Carlotti, F. (2021). 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation, 105(12), S26. https://doi.org/10.1097/01.tp.0000804432.75585.bf
Rajaei, Bahareh, et al. "402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes." Transplantation vol. 105,12 (2021): S26. doi: https://doi.org/10.1097/01.tp.0000804432.75585.bf
Rajaei B, Roelofsen AL, Shokrollahi E, Brinkhof B, Naumovska E, van der Sluis RJ, Nieveen M, Engelse M, de Koning E, Carlotti F. 402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes. Transplantation. 2021 Dec 01;105(12):S26. doi: 10.1097/01.tp.0000804432.75585.bf. PMID: 34908335.
Copy Download .nbib Format: NLM
Share it on

Transplantation. 2021 Dec 01;105(12):S26. doi: 10.1097/01.tp.0000804432.75585.bf.

402.1: Towards a GMP-Compliant Protocol for the Differentiation of Human Pluripotent Stem Cells to Beta-like Cells for the Treatment of Type 1 Diabetes.

Transplantation

Bahareh Rajaei, Annina L Roelofsen, Ehsan Shokrollahi, Bas Brinkhof, Elena Naumovska, Ronald J van der Sluis, Maaike Nieveen, Marten Engelse, Eelco de Koning, Françoise Carlotti

Affiliations

  1. Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands.

PMID: 34908335 DOI: 10.1097/01.tp.0000804432.75585.bf

[No abstract available.]

Publication Types